Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
dc.contributor.author | Berti, Alvise | |
dc.contributor.author | Warner, Roscoe | |
dc.contributor.author | Johnson, Kent | |
dc.contributor.author | Cornec, Divi | |
dc.contributor.author | Schroeder, Darrell | |
dc.contributor.author | Kabat, Brian | |
dc.contributor.author | Langford, Carol A. | |
dc.contributor.author | Hoffman, Gary S. | |
dc.contributor.author | Fervenza, Fernanado C. | |
dc.contributor.author | Kallenberg, Cees G. M. | |
dc.contributor.author | Seo, Philip | |
dc.contributor.author | Spiera, Robert | |
dc.contributor.author | St.Clair, E. William | |
dc.contributor.author | Brunetta, Paul | |
dc.contributor.author | Stone, John H. | |
dc.contributor.author | Merkel, Peter A. | |
dc.contributor.author | Specks, Ulrich | |
dc.contributor.author | Monach, Paul A. | |
dc.date.accessioned | 2018-07-13T15:47:34Z | |
dc.date.available | 2019-09-04T20:15:39Z | en |
dc.date.issued | 2018-07 | |
dc.identifier.citation | Berti, Alvise; Warner, Roscoe; Johnson, Kent; Cornec, Divi; Schroeder, Darrell; Kabat, Brian; Langford, Carol A.; Hoffman, Gary S.; Fervenza, Fernanado C.; Kallenberg, Cees G. M.; Seo, Philip; Spiera, Robert; St.Clair, E. William; Brunetta, Paul; Stone, John H.; Merkel, Peter A.; Specks, Ulrich; Monach, Paul A. (2018). "Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis." Arthritis & Rheumatology 70(7): 1114-1121. | |
dc.identifier.issn | 2326-5191 | |
dc.identifier.issn | 2326-5205 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/144646 | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.title | Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis | |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Rheumatology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/144646/1/art40471_am.pdf | |
dc.description.bitstreamurl | https://deepblue.lib.umich.edu/bitstream/2027.42/144646/2/art40471.pdf | |
dc.identifier.doi | 10.1002/art.40471 | |
dc.identifier.source | Arthritis & Rheumatology | |
dc.identifier.citedreference | Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. Genetically distinct subsets within ANCA‐associated vasculitis. N Engl J Med 2012; 367: 214 – 23. | |
dc.identifier.citedreference | Cornec D, Cornec‐Le Gall E, Fervenza FC, Specks U. ANCA‐associated vasculitis: clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol 2016; 12: 570 – 9. | |
dc.identifier.citedreference | Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody‐associated small‐vessel vasculitis. Ann Int Med 2005; 143: 621 – 31. | |
dc.identifier.citedreference | Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, et al. Clinical outcomes of treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis based on ANCA type. Ann Rheum Dis 2016; 75: 1166 – 9. | |
dc.identifier.citedreference | Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Arthritis Rheum 2013; 65: 1 – 11. | |
dc.identifier.citedreference | Ronnblom L, Eloranta ML. The interferon signature in autoimmune diseases. Curr Opin Rheumatol 2013; 25: 248 – 53. | |
dc.identifier.citedreference | Cornec D, Berti A, Hummel A, Peikert T, Pers JO, Specks U. Identification and phenotyping of circulating autoreactive proteinase 3‐specific B cells in patients with PR3‐ANCA associated vasculitis and healthy controls. J Autoimmun 2017; 84: 122 – 31. | |
dc.identifier.citedreference | Specks U, Merkel PA, Seo P, Spiera R, Langford CA, Hoffman GS, et al. Efficacy of remission‐induction regimens for ANCA‐associated vasculitis. N Engl J Med 2013; 369: 417 – 27. | |
dc.identifier.citedreference | Stone JH, Hoffman GS, Merkel PA, Min YI, Uhlfelder ML, Hellmann DB, et al, for the International Network for the Study of the Systemic Vasculitides (INSSYS). A disease‐specific activity index for Wegener’s granulomatosis: modification of the Birmingham Vasculitis Activity Score. Arthritis Rheum 2001; 44: 912 – 20. | |
dc.identifier.citedreference | Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA‐associated vasculitis. N Engl J Med 2010; 363: 221 – 32. | |
dc.identifier.citedreference | Lepse N, Land J, Rutgers A, Kallenberg CG, Stegeman CA, Abdulahad WH, et al. Toll‐like receptor 9 activation enhances B cell activating factor and interleukin‐21 induced anti‐proteinase 3 autoantibody production in vitro. Rheumatology (Oxford) 2016; 55: 162 – 72. | |
dc.identifier.citedreference | Berti A, Cavalli G, Campochiaro C, Guglielmi B, Baldissera E, Cappio S, et al. Interleukin‐6 in ANCA‐associated vasculitis: rationale for successful treatment with tocilizumab. Semin Arthritis Rheum 2015; 45: 48 – 54. | |
dc.identifier.citedreference | Monach PA, Warner RL, Tomasson G, Specks U, Stone JH, Ding L, et al. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA‐associated vasculitis. Ann Rheum Dis 2013; 72: 1342 – 50. | |
dc.identifier.citedreference | Monach PA, Tomasson G, Specks U, Stone JH, Cuthbertson D, Krischer J, et al. Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody–associated vasculitis. Arthritis Rheum 2011; 63: 3988 – 97. | |
dc.identifier.citedreference | Tanna A, Guarino L, Tam FW, Rodriquez‐Cubillo B, Levy JB, Cairns TD, et al. Long‐term outcome of anti‐neutrophil cytoplasm antibody‐associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant 2015; 30: 1185 – 92. | |
dc.identifier.citedreference | Fussner LA, Hummel AM, Schroeder DR, Silva F, Cartin‐Ceba R, Snyder MR, et al. Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3. Arthritis Rheumatol 2016; 68: 1700 – 10. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.